Suppr超能文献

家庭成员及护理人员对阿尔茨海默病症状前筛查的态度。

Attitudes of Family Members and Caregivers Regarding Alzheimer's Disease Pre-Symptomatic Screening.

作者信息

Makri Marina, Despoti Akyllina, Teichmann Birgit, Gkioka Mara, Moraitou Despina, Fidani Liana, Tegos Thomas, Tsolaki Magdalini

机构信息

Department of Neurology, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.

出版信息

J Alzheimers Dis Rep. 2024 Apr 18;8(1):723-735. doi: 10.3233/ADR-230145. eCollection 2024.

Abstract

BACKGROUND

In recent years, studies have examined the acceptability and attitudes that influence the intention to early screen for Alzheimer's disease (AD) in the general population, older people, carers, and asymptomatic individuals who report a family history of AD. However, it remains unclear what specific factors promote or reduce the acceptability of pre-symptomatic screening.

OBJECTIVE

The aim of this study is to explore the attitudes of family and non-family members as well as caregivers and non-caregivers toward the pre-symptomatic screening of AD.

METHODS

A total of 213 participants completed the Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening (PRE-ADS) Questionnaire. Group comparisons using t-test and one-way ANOVA were used to examine differences in attitudes toward pre-symptomatic screening regarding age, family history, knowing someone with AD, influence of depression, and feelings of anxiety. The subscale "Acceptability of Screening" was developed to investigate the willingness to undergo pre-symptomatic screening.

RESULTS

Participants with a family history showed greater acceptance of pre-symptomatic screening while both caregivers and non-caregivers had similar attitudes. People with a family history as well as those with personal connections to dementia indicate a greater need for knowledge. The findings suggest that younger adults appear to perceive less harm from testing, whereas those who experience higher levels of anxiety and depression seem to perceive more testing harms.

CONCLUSIONS

Comparing the attitudes of people with and without a family history as well as caregivers and non-caregivers toward pre-symptomatic screening of AD is critical to understand the differences between these groups and develop comprehensive screening programs.

摘要

背景

近年来,已有研究调查了普通人群、老年人、护理人员以及有阿尔茨海默病(AD)家族病史的无症状个体中影响早期筛查AD意愿的可接受性和态度。然而,仍不清楚哪些具体因素会促进或降低症状前筛查的可接受性。

目的

本研究旨在探讨家庭成员与非家庭成员以及护理人员与非护理人员对AD症状前筛查的态度。

方法

共有213名参与者完成了关于症状前阿尔茨海默病筛查(PRE-ADS)问卷的认知调查。使用t检验和单因素方差分析进行组间比较,以检验在年龄、家族病史、认识AD患者、抑郁影响和焦虑感方面对症状前筛查态度的差异。编制了“筛查可接受性”子量表来调查接受症状前筛查的意愿。

结果

有家族病史的参与者对症状前筛查的接受度更高,而护理人员和非护理人员的态度相似。有家族病史的人和与痴呆症有个人关联的人表示对知识有更大需求。研究结果表明,年轻人似乎认为检测带来的危害较小,而那些焦虑和抑郁程度较高的人似乎认为检测危害更大。

结论

比较有家族病史和无家族病史的人以及护理人员和非护理人员对AD症状前筛查的态度,对于了解这些群体之间的差异以及制定全面的筛查计划至关重要。

相似文献

1
Attitudes of Family Members and Caregivers Regarding Alzheimer's Disease Pre-Symptomatic Screening.
J Alzheimers Dis Rep. 2024 Apr 18;8(1):723-735. doi: 10.3233/ADR-230145. eCollection 2024.
5
6
9
Older primary care patients' attitudes and willingness to screen for dementia.
J Aging Res. 2015;2015:423265. doi: 10.1155/2015/423265. Epub 2015 Apr 20.

引用本文的文献

1
Mesenchymal stem cell application in Alzheimer's disease.
Regen Ther. 2025 Jul 26;30:439-445. doi: 10.1016/j.reth.2025.07.006. eCollection 2025 Dec.

本文引用的文献

3
Building Strong Primary Healthcare Systems in Greece.
Cureus. 2023 Jul 3;15(7):e41333. doi: 10.7759/cureus.41333. eCollection 2023 Jul.
4
Dementia prevention in memory clinics: recommendations from the European task force for brain health services.
Lancet Reg Health Eur. 2023 Jan 31;26:100576. doi: 10.1016/j.lanepe.2022.100576. eCollection 2023 Mar.
6
Current trends in blood biomarker detection and imaging for Alzheimer's disease.
Biosens Bioelectron. 2022 Aug 15;210:114278. doi: 10.1016/j.bios.2022.114278. Epub 2022 Apr 12.
7
Depression among caregivers of patients with dementia: Associative factors and management approaches.
World J Psychiatry. 2022 Jan 19;12(1):59-76. doi: 10.5498/wjp.v12.i1.59.
8
Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention.
Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.
9
Dementia risk communication. A user manual for Brain Health Services-part 3 of 6.
Alzheimers Res Ther. 2021 Oct 11;13(1):170. doi: 10.1186/s13195-021-00840-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验